Evidence map›Paper›PMID 39497134›Full record

ReviewJournal of nanobiotechnology2024

Nitric oxide-based multi-synergistic nanomedicine: an emerging therapeutic for anticancer.

Yaqin Tang, Qiyu Li, Ziwei Zhou, Huayang Bai, Nianting Xiao, Jing Xie, Chong Li

Abstract readReview
In one paragraph

Review in Journal of nanobiotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Hollow MnOInternational journal of nanomedicine · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Subcellular Localization Guides eNOS Function.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yaqin TangChongqing Key Laboratory of Medicinal Chemistry and Molecular Pharmacology, Chongqing University of Technology, Chongqing, 400054, People's Republic of China.
Qiyu LiChongqing Key Laboratory of Medicinal Chemistry and Molecular Pharmacology, Chongqing University of Technology, Chongqing, 400054, People's Republic of China.
Ziwei ZhouChongqing Key Laboratory of Medicinal Chemistry and Molecular Pharmacology, Chongqing University of Technology, Chongqing, 400054, People's Republic of China.
Huayang BaiChongqing Key Laboratory of Medicinal Chemistry and Molecular Pharmacology, Chongqing University of Technology, Chongqing, 400054, People's Republic of China.
Nianting XiaoChongqing Key Laboratory of Medicinal Chemistry and Molecular Pharmacology, Chongqing University of Technology, Chongqing, 400054, People's Republic of China.
Jing XieChongqing Key Laboratory of Medicinal Chemistry and Molecular Pharmacology, Chongqing University of Technology, Chongqing, 400054, People's Republic of China. xiejing33@cqut.edu.cn.
Chong LiCollege of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, China. chongli@swu.edu.cn.

Funding

Risk factors for post-operative complications after oral surgery in VeteransI01HX000210 · VA · BIRMINGHAM VA MEDICAL CENTER · PI BARASCH, ANDREI · 2009 to 2009
–
HSRD VA I01 HX000210the Chongqing Natural Science Foundation Postdoctoral Science Fund Project CSTB2023 NSCQ-BHX0210the graduate innovation and Entrepreneurship Project of Chongqing University of Technology gzlcx20243236the Graduate Scientific Research and Innovation Foundation of Chongqing, China CYS240720the Graduate Scientific Research and Innovation Foundation of Chongqing, China CYS240721the National Natural Science Foundation of China 22307012the Natural Science Foundation Project of CQCSTC cstc2021-jcyj-msxmX0382the Science and Technology research program of Chongqing Education Commission of China KJQN202101140the Science and Technology research program of Chongqing Education Commission of China KJQN202201168
6 · The paper itself

Abstract

Gas therapy has emerged as a promising approach for treating cancer, with gases like NO, H

Indexed as

Antineoplastic AgentsNanomedicineNeoplasmsNitric OxideNitric Oxide DonorsAnimalsDrug Delivery SystemsHumansNanoparticlesAntineoplastic AgentsNitric OxideNitric Oxide DonorsCancer therapyNitric oxideResponsive nanoparticlesSynergistic nanomedicine

Identifiers

PMID39497134
PMCPMC11536969

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.